Fine mapping of matrix metalloproteinase 16 (MMP16) gene: Validation of a significant association with bronchopulmonary dysplasia (BPD)
A. Hadchouel Duvergé, F. Decobert, I. Layouni, P. H. Jarreau, R. Lenclen, M. L. Franco-Montoya, J. Bourbon, C. Delacourt (Créteil, Paris, Poissy, France)
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Hadchouel Duvergé, F. Decobert, I. Layouni, P. H. Jarreau, R. Lenclen, M. L. Franco-Montoya, J. Bourbon, C. Delacourt (Créteil, Paris, Poissy, France). Fine mapping of matrix metalloproteinase 16 (MMP16) gene: Validation of a significant association with bronchopulmonary dysplasia (BPD). Eur Respir J 2010; 36: Suppl. 54, 3550
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Matrix metalloproteinase (MMP) 9 is associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Matrix metalloproteinase (MMP) 12 is not associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006
Matrix metalloproteinase (MMP ) -1 and -3 promoter polymorphisms in Bulgarian patients with COPD Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011
Genes of detoxication system, matrix metalloproteinase 9 (MMP9) and set of group factors of blood in the risk of development of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 63s Year: 2004
Matrix metalloproteinases (MMPs), tissue inhibitor of matrix metalloproteinases (TIMPs) and transforming growth factor-β (TGFβ) expression in small airways (SA) of usual idiopathic pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hip Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease Year: 2007
Effects of glutation-S-transferase M1 (GSTM1) and T1 (GSTT1) and matrix metalloproteinase 9 (MMP9) on the decline of lung function in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 63s Year: 2004
Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2007; 30: Suppl. 51, 137s Year: 2007
Matrix metalloproteinase 2 expression in distal lung of fatal asthma Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006
Remodelling of extracellular matrix (ECM) differs between pulmonary adenocarcinoma (Ad) and squamous cell carcinoma (Sq): immunohistochemistry and morphometry of matrix proteins (MPs), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008
A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAMTS18) is a novel regulator of BPD Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018
Activity of matrix metalloproteinases and their inhibitor in children with bronchopulmonary dysplasia Source: Annual Congress 2009 - Respiratory physiology in infants and preschool children, in health and disease Year: 2009
Quantitative assessment of matrix metalloproteinasis 7 (MMP-7) and tissue inhibitor of MMP-7 (TIMP1) in NSCLC tissue samples Source: Eur Respir J 2006; 28: Suppl. 50, 813s Year: 2006
The genetic polymorphism of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011
Temporal analysis of macrophage infiltration, expression of metalloproteinase 12 and isoprostane-8 in an experimental model of emphysema Source: Annual Congress 2010 - Proteases and the matrix Year: 2010
-82 A>G promoter polymorphism in the gene of human macrophage elastase (MMP-12) as a risk factor for COPD and bronchial asthma Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014
Matrix metalloproteinase (MMP) 12 is associated with clinical parameters of disease severity and exacerbations in asthma Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010
Remodelling of extracellular matrix (ECM) differs between tumor centre and invasion front in human non-small cell lung cancer: immunohistochemistry and morphometry of matrix proteins (MP), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (T Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008
Polymorphism of multidrug resistance gene (MDR1), interleukin 4 (IL4), IL13 genes in asthmatic patients and patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
Repeat polymorphisms (pol.) in the NOS-1 gene and its association with the clinical severity of cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010